Search results
-
Awards and certifications
Many aspects of our sustainability commitment have been recognised externally, and we actively seek certification in key areas of our operations.
-
Partner with us
Innovation thrives when it’s driven by a diverse mix of ideas, this is why we always look to collaborate and share insight with our industry partners.
-
Our strategy
Our focus on innovation, sustainability and growth ensures that Croda smart science helps our customers meet their own sustainability targets as well as consumer demands.
-
Megatrends
Trends which will influence market demand and growth at Croda, Providing new opportunities and shaping our approach.
-
Policies and procedures
We operate a range of policies covering all area of our Business to uphold the principles of socially responsible business practices.
-
Our centenary
2025 is Croda’s centenary year which provides an excellent opportunity to celebrate our rich history and reflect on the strong foundations it gives us for future success.
-
Our Values
At Croda, our company core values of Responsible, Innovative, and Together are at the heart of how we operate, shaping a unique, collaborative culture that supports our Purpose.
-
Nature Positive
By 2030, we will be Nature Positive.
-
Modern slavery
The Modern Slavery Act was introduced in 2015. It requires larger businesses to report annually the steps that they are taking to reduce the risk of slavery and human trafficking taking place within their supply chains or in any part of their businesses. Read Croda's statement here.
-
Governance
Our Board are responsible for good governance and are committed to the highest standards of corporate governance.
-
Our Fundamentals
We will consider all stakeholders in our ecosystem and adopt best practices in environment, labour and human rights, ethics and sustainable procurement.
-
Our targets
We are developing our sustainability strategy to 2030, ensuring our alignment to the United Nations Sustainable Development Goals (SDGs).
-
Safety
Behavioural and process safety are extremely important for us at Croda, the safety of our employees and neighbours is of paramount importance.
-
Leadership
Our Board and Executive Committee provide leadership in delivering for our customers and achieving our strategic priorities.
-
Behind the Science
Discover how Croda’s high-quality ingredients, scientific expertise and sustainable innovation deliver end-to-end solutions that power growth across Consumer Care and Life Sciences.
-
Current vacancies
At Croda, our people are our difference. We are committed to using Smart science to improve lives™ while driving a sustainable future. Join our team and be part of a responsible, inclusive culture where your contributions make an impact.
-
Meet the expert: Dhanila Varkey, Applications Team Lead
Discover how Croda’s applications expert Dhanila Varkey is using nanotechnology to improve targeting, absorption and effectiveness in topical and transdermal drug delivery.
-
Croda Foundation
Introduction to the Croda Foundation, the independently managed, philanthropic arm of Croda International.
-
Meet the expert: Will Small, Research & Technology Specialist
Will shares how high-purity and super refined excipients help improve consistency and stability, and how they’re being leveraged in new active formulations to drive innovation and growth.
-
Meet the expert: Chris Wells, Applications Team Lead
Meet the expert: Chris Wells, Applications Team Lead
-
Your ingredients partner powering health innovation
Explore how Croda’s smart science, people and high-performance ingredients are shaping the future of Life Sciences and enabling safer, more sustainable innovation.
-
Sustainability Impact Report 2024
Find our 2024 Sustainability Impact Report here
-
Steve Foots, CEO Sustainability Statement 2024
One of our core philosophies is to take a leadership position in sustainability and innovation in our chosen markets.
-
Materiality assessment
Our Materiality Assessment performed a comprehensive value chain assessment, and identified areas of transformative action within the business
-
Sustainability Report archive
View our sustainability report archives.
-
Croda named Britain’s Most Admired Chemicals Company for the tenth time, extending an exceptional record of sustained peer recognition
20 January 2026: Croda International Plc has been named Britain’s Most Admired Chemicals Company for the tenth time, highlighting its leadership in smart science and high-performance ingredients.
-
Croda acquired crop enhancement company Plant Impact
Plant Impact identifies ways to improve the yield and quality of crops by stimulating or moderating plant responses in both healthy and stressed crops during key growth stages.
-
Acquisition of global vaccine adjuvant specialist
Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.
-
Croda acquires marine biotechnology specialists Nautilus
World class scientists, focusing on using marine microbial biodiversity to discover novel actives and materials for applications across all Croda market sectors.
-
Our business model
Our business model is designed to create long-term, sustainable value.
-
Croda acquires Inventiva, encapsulation and delivery system technology
It will form the basis of a research and technology platform for the encapsulation and delivery of Croda’s products, providing a new dimension in the company’s innovation programme.
-
Croda acquires research enterprise Enza Biotech
Developing the next generation of renewable surfactants using carbohydrate-based chemistry.
-
Croda expands Iberchems fragrances offering with the acquisition of Parfex
Croda has acquired a controlling majority 95.6% of Parfex’s outstanding shares, comprising the founding shareholders and certain minority investors.
-
Acquisition of Alban Muller
The acquisition expands Croda’s portfolio of sustainable active ingredients for customers in personal care markets.
-
Shareholder centre
Useful information for Croda Shareholders.
-
Croda acquires innovative seed enhancement company Incotec
Operating in one of the fastest growing segments within the crop care market, Incotec develop and supply a wide range of proprietary and sustainable technologies for both vegetable seeds and field crops.
-
Acquisition of Iberchem expands reach into high growth fragrances market
Acquiring the entire issued share capital of Fragrance Spanish Topco, S.L., trading as Iberchem (“the acquisition”), a leading global fragrances and flavours (“F&F”) company.
-
Strengthening Life Sciences with the acquisition of Avanti Polar Lipids
A leader in drug delivery systems for next generation pharmaceuticals, the acquisition more than doubles Croda’s research and development (R&D) capability in drug delivery.
-
Shareholder information
Keep up to date with shareholder and investor information.
-
Strategic investment Entekno Materials
A new Smart Partnership focused on the development of a new particle technology that will deliver superior protection benefits to the sun care and personal care markets.
-
Acquisition of global vaccine adjuvant specialist
Vaccine adjuvants are a natural extension to Croda’s market leading, high-purity excipient delivery systems in its Health Care business., these adjuvants represent a niche, high-growth market.
-
Vietnam
Croda’s Vietnam office was founded in 2012 and is located in Ho Chi Minh City.
-
Sustainability Committee
Responsible for global Group-wide engagement with our sustainability targets and providing guidance and support to sites, regions and sectors to develop plans to deliver our sustainability goals.
-
Validation of our 1.5°C Science Based Targets
We have become one of only three major chemical companies in the world to have our 1.5°C Science Based Targets validated.
-
Crodarom expands its Chanac France site
Crodarom, producer of botanical extracts, is launching its first investment program to expands its Chanac production site location in France.
-
Task force for more sustainable polymers
Helping create a more sustainable future as founder members of the Polymers in Liquid Formulations task force.
-
Croda calls on the UK Government to deliver a clean and just recovery plan
We are proud to be one of 200 UK businesses that have called on the UK Government to deliver a ‘clean and just’ recovery plan
-
Alganelle Sederma partnership
A partnership to create a cosmetic active ingredient of the future
-
Mexico
In 1977, a joint venture company was formed in Mexico, Quimica Croda SA.
-
Croda becomes founding member of sustainability Business Transformation Group
We are proud to be a founding member of the CISL Business Transformation Group.
-
Annual Report archive
Annual reports from previous years.
-
Croda announces registered name for its innovative non-animal keratin for hair repair.
14 July 2025: Croda International Plc today announce registered name for its innovative non-animal keratin for hair repair.
-
Croda joins the Together for Sustainability initiative
Croda becomes the 30th member of TfS
-
CrodaTherm helps COVID19 nurses in The Netherlands
CrodaTherm™ helps reduce heat strain experienced by COVID-19 nurses in The Netherlands
-
Croda supports Kayapo indigenous people during COVID19
We are continuing to support local communities during the COVID-19 pandemic by providing soap bars to indigenous communities in Brazil
-
Celebrating a century of Croda
Croda marks 100 years with global celebrations highlighting our people, history, and commitment to our Purpose: Smart science to improve lives™.
-
Driving innovation in the Agriculture market
Through Croda’s acquisition of the Incotec Seed Enhancement business in 2015 and the Plant Impact Biostimulants business in 2018, we are well placed to address some of the challenges in the adoption of biologics.
-
CroBioticTM 100
Surveys indicate that malodour of garments is one of the biggest reasons that consumers choose to wash them.
-
Customer award for carbon reduction
We’ve been working in partnership with Syngenta to deliver innovative and sustainable ingredients in a way that meets their commercial and sustainability goals.
-
Sustainability without compromise ChromaPur
Small, manufactured plastic particles, known as microbeads, are used in a wide range of cosmetic and personal care products, with research suggesting that 87% of products from the ten best-selling cosmetics brands contain these microplastics.
-
Leveraging Group-wide capabilities to accelerate the development of natural active ingredients
The move in cosmetics towards replacing synthetic ingredients with sustainable alternatives is increasing demand for naturally sourced actives.
-
Croda and Anome Collaboration Promises a Positive Difference in Beauty Effects
We are very proud to announce a new collaborative partnership with Anomera, an award-winning innovator in green chemistry, materials science and sustainable manufacturing.
-
Biodegradable fragrance encapsulation
Fragrance encapsulation involves advanced delivery systems that allow the timed release of fragrances, critical in various applications such as laundry, fabric softeners and deodorants.
-
Croda donates solar panel modules to non-profit organisations
We have donated 1,000 SunPower solar panels to three non-profit organizations for use in low-income housing and crop generation.
-
Croda supports Pfizer-BioNTech COVID-19 vaccine
Avanti, a company we acquired in 2020, has a strong track record in supplying R&D quantities of lipid-based drug delivery technologies to pharmaceutical companies including those developing mRNA drugs.
-
Investing in organic expansion in Agriculture
Atlox 4913TM is valued by customers for creating stable dispersions in complex crop formulations, ensuring consistent distribution of actives and preventing formulation breakdown.
-
Symiro™ biostimulant
As the challenge to feed our growing global population continues, increasing crop growth and yields is becoming an important area of focus to meet the rising demand for food.
-
Singapore
Croda Singapore was founded in 1986 and is the regional headquarters of the Asia Pacific region.
-
India
Croda India's manufacturing site was founded in 1995 and is located at Navi Mumbai.
-
Being a woman at Croda International Women's Day 2020
We are proud to support and celebrate incredible and extraordinary woman all over the world. This IWD, Marketing Associate, Kira Drabble has written an article about what it means to be a woman at Croda and how Croda are embodying the IWD theme this year #EachforEqual.
-
Paulo Sevilha becomes the new chairman of the Brazilian Cosmetic Association ABC
The great news is that, for the first time in its history, the entity will be directed by a representative from the cosmetic ingredients industry. It is a pleasure to announce that Paulo Sevilha, Latin America Consumer Care Regional Sales and Marketing Director, will lead the entity.
-
International chemicals leader Croda expands presence at Techspace One
Croda has expanded its presence at Sci-Tech Daresbury in line with plans to scale up its biotechnology capability.
-
Winners of the CIA Awards Company of the Year
Croda have been named the Chemical Industry Association (CIA) company of the year
-
Contract for innovative delivery system for COVID19 vaccine
We have recently entered into an agreement with Pfizer Inc. to supply novel excipients used in the manufacture of a COVID-19 vaccine candidate.
-
Croda expands its high purity pharmaceutical excipients manufacturing capability
Croda has announced the expansion of its Mill Hall high purity excipients facility.
-
Acts of kindness continue in local communities
We are is continuing to support communities around our manufacturing sites through the Acts of Kindness initiative
-
Croda Wins Syngenta Supplier Partnership Award 2020
Croda International Plc, who create, make and sell high performance ingredients that are relied on by industries and consumers everywhere, are delighted to have won the Syngenta Supplier Partnership Award at the 2020 Virtual Syngenta Supplier Conference.
-
Appointment of Non -Executive Director
We are pleased to announce the appointment of Julie Kim as non-executive director.
-
Croda invests in biopharma innovation with expanded Super Refined™ facility in Leek, UK
25 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, continues to invest in the evolving world of biopharmaceutical manufacturing where consistency and purity in ingredients are critical.
-
Croda Executive Committee walk Yorkshire Three Peaks
Our Executive Committee has pledged to raise vital funds to support COVID-19 relief in India.
-
Croda Singapore shortlisted for two IChemE Global Awards 2020
We are celebrating being shortlisted in two categories for the Global IChemE Awards 2020.
-
Croda Awarded Best product innovation at the Global ICIS Innovation Awards
Croda are delighted to have been awarded ‘Best Product Innovation’ in the Global ICIS Innovation Awards 2019
-
Croda receives EcoVadis Platinum status
Croda is this month celebrating being awarded the new Platinum status by EcoVadis.
-
Croda celebrates milestone in digital transformation
Celebrating a significant milestone in our digital customer enhancement journey with the launch of our Smart Materials website.
-
Ranked first in Barrons most sustainable international company listing
We have recently been ranked first in the Most Sustainable International Company rankings by Barron’s.
-
Record performance driven by accelerated strategic implementation
Croda International results for the six months ended 30 June 2021
-
Strategic review of Performance Technologies and Industrial Chemicals businesses
The core objective will be to establish what ownership structure best serves this part of Croda’s business going forward, to create a stronger platform for its future growth.
-
Strong strategic delivery built on resilient financial performance
Croda 2020 full-year results, strong strategic delivery built on resilient financial performance
-
Appointment of Non-Executive Director, Jill Anderson
9 January2026: We are pleased to announce the appointment of Jill Anderson as Non-Executive Director.
-
Sentient Science and Croda partner for wind asset life extension
Croda announce a new partnership with Sentient Science for the recommended use of Croda’s Rewitec additives
-
Construction underway on our new North American Headquarters and innovation centre
The sustainable facility will bring together commercial and technical teams from across our business areas
-
Supporting local school children during lockdown
We are supporting school children in the UK by gifting our pre-owned laptops and tablets to pupils having lessons at home
-
Croda urges G20 leaders to keep Paris Agreement within reach
Croda is signatory to an open letter to all G20 leaders, urging them to keep the Paris Agreement’s 1.5°C goal within reach.
-
Signatory to the if not now then when campaign
We have joined over 70 major UK businesses in becoming a signatory to the Black inclusion business campaign.
-
Celebrating our innovative ingredients: Zenakine™ - redefining neurocosmetic skincare possibilities
8 September 2025: Croda International Plc (“Croda”), the company that uses smart science to create high-performance ingredients and solutions that improve lives, has recently launched Zenakine™, a biotech-based neuroactive ingredient designed to counteract the effects of stress on the skin.
-
Croda Half Year Results fireside chat with Morgan Stanley
Watch our fireside chat with Morgan Stanley from 29 July 2025.
-
PTIC divestment
View the full webinar from the 22 December 2021 discussing the agreement to divest the majority of our PTIC businesses to Cargill Inc.
-
Third quarter trading update
Update on trading from 01 July to 30 September 2023
-
Half year 2024 results
Group performance in line with expectations reflecting more stable market conditions and operational progress
-
UK Government to support expansion of Croda's lipid systems manufacturing facility
31 March 2022: This investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines.